Cormorant Private Healthcare Fund II, LP insider trades: MoonLake Immunotherapeutics (MLTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cormorant Private Healthcare Fund II, LP reports to the SEC
and 6 more companies
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | MLTX | ↓ Sell | 6,499,978 | $7.21 | $46.9M | Indirect | Oct 1, 2025 (1d) |
| Oct 5, 2023 | MLTX | ↑ Buy | 58,839 | $59.90 | $3.5M | Indirect | Oct 10, 2023 (5d) |
| Oct 4, 2023 | MLTX | ↑ Buy | 293,212 | $57.30 | $16.8M | Indirect | Oct 4, 2023 (0d) |
| Dec 13, 2022 | ERAS | ↑ Buy | 307,692 | $6.50 | $2.0M | Indirect | Dec 20, 2022 (7d) |
| Jul 20, 2021 | ERAS | ↑ Buy | 950,000 | $16.00 | $15.2M | Indirect | Jul 22, 2021 (2d) |
| Jul 2, 2021 | AVTE | ↑ Buy | 500,000 | $14.00 | $7.0M | Indirect | Jul 7, 2021 (5d) |
| Jun 28, 2021 | GLUE | ↑ Buy | 600,000 | $19.00 | $11.4M | Indirect | Jun 30, 2021 (2d) |
| Apr 27, 2021 | RAIN | ↑ Buy | 450,000 | $17.00 | $7.7M | Indirect | Apr 29, 2021 (2d) |
| Mar 30, 2021 | DSGN | ↑ Buy | 750,000 | $20.00 | $15.0M | Indirect | Apr 1, 2021 (2d) |
| Dec 18, 2020 | BCAB | ↑ Buy | 800,000 | $18.00 | $14.4M | Indirect | Dec 22, 2020 (4d) |
| Nov 23, 2020 | OLMA | ↑ Buy | 425,000 | $19.00 | $8.1M | Indirect | Nov 23, 2020 (0d) |
| Jun 30, 2020 | AKUS | ↑ Buy | 290,000 | $17.00 | $4.9M | Indirect | Jul 2, 2020 (2d) |
| Jun 16, 2020 | RNA | ↑ Buy | 300,000 | $18.00 | $5.4M | Indirect | Jun 18, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLTX insiders
Open-market trades in the last 12 months
About Cormorant Private Healthcare Fund II, LP's insider trades
Cormorant Private Healthcare Fund II, LP is an insider at MoonLake Immunotherapeutics (MLTX). Since Jun 16, 2020, it has reported 12 open-market purchases worth $111.4M and 1 sale worth $46.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (10 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.